Intas Pharma, Meiji, Dong-A ST ink licensing agreement for biosimilar to Ustekinumab ruchika24 July 2021 3:30 AM GMTAhmedabad: Intas Pharmaceuticals Ltd has announced that the company has entered into an exclusive license agreement with Meiji and Dong-A Socio Holding...
NPPA panel fixes price of Intas Pharma oncology drug, Details Medical Dialogues Team27 Jun 2021 4:45 AM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of an oncology drug combination pack of T...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 11:26 AM GMTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue show-caus...
Intas Pharma launches immuno booster add on drug to standard Covid treatment ruchika12 Nov 2020 5:45 AM GMTThymoquinone has been developed as a stable, standardized and ready-to-use tablet by Intas for the first time in the world.
Intas Pharma COVID-19 specific Hyperimmune Globulin gets DCGI nod to conduct clinical trial ruchika30 Aug 2020 5:00 AM GMTIntas is among the world's first to adopt this approach for treating COVID-19 patients. This will be a Corporate Social Responsibility (CSR)...
NPPA fixes retail prices of 30 formulations, defers Sun Pharma, Micro Labs new drug applications Farhat Nasim23 Aug 2020 7:13 AM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed prices of 30 form...
